XYNOMIC PHARMACEUTICALS HOLDINGS, INC. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2019)

-$25.1M

Total Assets (FY2019)

$937.5K

Total Equity (FY2019)

-$22.6M

Cash Flows from Operating Activities (FY2019)

-$10.7M

Source: XYNOMIC PHARMACEUTICALS HOLDINGS, INC. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.